Hybridoma-derived neutralizing monoclonal antibodies against Beta and Delta variants of SARS-CoV-2 in vivo.
Wang Q, Peng L, Nie Y, Shu Y, Zhang H, Song Z, Li Y, Hu H, Li L, Wang X, Liu J, Li J, Shi Z, Deng F, Guo Y, Zhou Y, Yan B, Hu Z, Wang M.
Wang Q, et al. Among authors: shu y.
Virol Sin. 2023 Apr;38(2):257-267. doi: 10.1016/j.virs.2022.12.007. Epub 2022 Dec 31.
Virol Sin. 2023.
PMID: 36596381
Free PMC article.